West Nile Virus Seroprevalence in a Selected Donkey Population of Namibia.
Namibia
antibody
cELISA test
donkeys
usutu virus
west nile virus
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2021
2021
Historique:
received:
16
03
2021
accepted:
26
05
2021
entrez:
5
7
2021
pubmed:
6
7
2021
medline:
6
7
2021
Statut:
epublish
Résumé
West Nile Virus (WNV) is a mosquito-borne virus enzootically maintained in birds. However, it can incidentally infect other species, leading to sometimes severe clinical consequences like in horses and especially human beings. Despite the topic relevance, the presence and distribution of WNV are currently unknown in Namibia. Several countries implement surveillance systems based on virus detection in birds, mosquitoes, and vertebrate species including horses. The present study aimed to fill this knowledge gap by serologically evaluating WNV exposure in Namibian donkeys, whose population is remarkably bigger than the horse one. Forty-seven out of 260 sampled animals showed neutralizing antibodies against WNV (18.07% [95% CI = 13.59-23.30%]), demonstrating its circulation in all country territory, although, with apparent regional differences. On the contrary, no association with animal age or sex could be identified. The present study demonstrates the widespread presence of WNV in Namibia as well as the practical utility and effectiveness of donkeys as sentinels for infection surveillance. Due to clinical relevance, vaccination campaigns should be considered for horses of high economic or genetic value. Additionally, the burden of WNV infection on human health should be carefully evaluated.
Identifiants
pubmed: 34222404
doi: 10.3389/fvets.2021.681354
pmc: PMC8249584
doi:
Types de publication
Journal Article
Langues
eng
Pagination
681354Informations de copyright
Copyright © 2021 Molini, Franzo, Nel, Khaiseb, Ntahonshikira, Chiwome, Baines, Madzingira, Monaco, Savini and D'Alterio.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Equine Vet J. 2003 Sep;35(6):601-5
pubmed: 14515962
Vet J. 2012 Nov;194(2):262-4
pubmed: 22633828
Pathogens. 2020 Dec 30;10(1):
pubmed: 33396935
Infect Drug Resist. 2020 May 20;13:1491-1497
pubmed: 32547118
Comp Immunol Microbiol Infect Dis. 2017 Feb;50:8-12
pubmed: 28131384
Trop Med Int Health. 2004 Jun;9(6):730-6
pubmed: 15189465
Am J Trop Med Hyg. 1999 Dec;61(6):885-8
pubmed: 10674664
Vet Microbiol. 2013 Nov 29;167(1-2):168-80
pubmed: 24035480
Pathogens. 2020 Dec 11;9(12):
pubmed: 33322276
PLoS Negl Trop Dis. 2017 Sep 15;11(9):e0005936
pubmed: 28915240
Ann N Y Acad Sci. 2001 Dec;951:143-52
pubmed: 11797772
Transbound Emerg Dis. 2019 Jan;66(1):445-453
pubmed: 30318735
Emerg Infect Dis. 2019 Dec;25(12):2290-2294
pubmed: 31742510
Transbound Emerg Dis. 2016 Dec;63(6):e153-e159
pubmed: 25753775
Vet World. 2020 May;13(5):1005-1009
pubmed: 32636601
Trans R Soc Trop Med Hyg. 2021 May 8;115(5):566-568
pubmed: 33053581
Clin Vaccine Immunol. 2014 Oct;21(10):1460-2
pubmed: 25100824
Clin Lab Med. 2010 Mar;30(1):47-65
pubmed: 20513541
Parasit Vectors. 2018 Jul 13;11(1):414
pubmed: 30005653